Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Something has to happen soon. SMARTICLES is a great formulation
I think you are probably right
Now the manipulation can stop and the stock can rise now that everyone with the warrants got their cheap shares! This stock manipulation greed game is such crap! People dying waiting for cures and idiots have to steal companies and play games!
Now that key employees have their new stock options priced maybe good news will be released in the future. Now the stock can rise!
We all want news but it will be months before anything significant happens. These little companies move like turtles
Anyone hear anything about the meeting today?
So we should at least be at $4 million market cap based on Regen at $23 million
Does BMSN own only 18% of Regen?
What percent of Regen is owned by BMSN?
Excellent news! Market is bad for all stocks but we will probably get a cash infusion with a licensing deal. Patience is a must. Marina is an undervalued gem.
All these little microcap bios are disappointing. I think I'm done posting. I'll hold what I have until it goes back to hopefully 4 some day soon. Maybe someone else can be a moderator here.
I am long Mabvax and would like to buy more here but need one of my other biotechs to go up!
Just hope French sells the company soon!
In the long run a good stock to own, but all these OTC biotechs are crap in the short term.
The full Zacks new coverage report mentions that the new antibodies are being directed toward Ewing's sarcoma and osteosarcoma. Interesting. Lots to like here just a waiting game for the fireworks to start.
On second thought this management team is terrible. Billion dollar biotech fortunes have been built in the last 4 years and Marina has gone nowhere.
Great right back where we were last week. Someone is manipulating this stock
I think management is now finally making the right moves but it has taken some time to get here. We have to re establish credibility in time estimates for milestones and I think they are doing that now. The fact that we fell off the radar and went to the pink sheets years ago is a reason why TPIV is now such a compelling investment. Our science is on par with Juno, they just went public at the right time.
You are seeing it correctly! Juno went public just as immunotherapy grabbed the spotlight. TapImmune is on the pink sheets and has been for years. Bad luck and weak management put us here but the great science will eventually win.
TapImmune has much larger target markets in solid rumors than Juno has with blood cancers
Well gotta believe Michael French has our best interests at heart side he owns over 700K shares.
Great find! Thanks for posting. Thinking we move up strongly now from 2.52!
Right on cue manipulation down to 2.33 once it ran up to 2.57
I think we have had bad management. Shame because science is great.
Disgusting to see Juno at $57 and TapImmune at 76 cents.
Well the entity trying to keep Mabvax around 2.33 is right on time! Squelch any rise in the stock. Something big must be brewing.
Looking strong on a horrible day in the market
Wish someone would convince Mayo to publicly praise and recognize TapImmune.
C'mon Dart you are now in this with us. Put some pressure on Mayo to publicly praise TapImmune for their work on this vaccine as a great partner.
I completely agree. Like a big institution selling when the price starts moving above 2.30. Maybe a big institution that wants to buy a few million shares in a private placement around $2.30.
Didn't Glynn mention that they were going to release more info on the HER2/neu breast cancer Phase 1
results?
HER2 is also over expressed in ovarian cancer and well, but reports vary on the percentage.
Yes Phase 2 will start in 3Q. I like how Keith in that video thinks that TapImmune may apply TAP to other indications beyond breast and ovarian cancer.
I am in this for the long haul now as I did not sell at 1.80 last March
Mabvax is the only company isolating antibodies from the blood of vaccinated patients to my knowledge.
As a moderator I can only sticky one post and used mine on a jbem post last month.
Sorry but can't look at it until Fri as I am traveling without my computer. If you post 4 messages you can apply to be a moderator as well.
I won't sell until our market cap is $ 5 billion.
I wish Michael French would sell the company at $5 per share and let us invest elsewhere. Taking too long
I won't sell until it hits at least $10!